HeartBeam, Inc. (BEATW)
USD 0.7
(-14.63%)
USD 0.7
(-14.63%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 17.13 Million USD | 324.14% |
| 2022 | 4.03 Million USD | -71.15% |
| 2021 | 13.99 Million USD | 27347.06% |
| 2020 | 51 Thousand USD | 628.57% |
| 2019 | 7000.00 USD | -100.0% |
| 2018 | 586.8 Million USD | 11.86% |
| 2017 | 524.56 Million USD | 163.62% |
| 2016 | 198.98 Million USD | 60.29% |
| 2015 | 124.14 Million USD | -0.51% |
| 2014 | 124.77 Million USD | 42.53% |
| 2013 | 87.54 Million USD | -2.74% |
| 2012 | 90.01 Million USD | -5.23% |
| 2011 | 94.97 Million USD | -39.39% |
| 2010 | 156.69 Million USD | -6.91% |
| 2009 | 168.32 Million USD | 1.54% |
| 2008 | 165.77 Million USD | 60.88% |
| 2007 | 103.03 Million USD | 500.11% |
| 2006 | 17.17 Million USD | 0.0% |
| 2004 | 22.8 Million USD | 2.94% |
| 2003 | 22.15 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 10.12 Million USD | -25.74% |
| 2024 Q1 | 13.63 Million USD | -20.41% |
| 2023 Q3 | 19.64 Million USD | -9.17% |
| 2023 Q1 | 1.46 Million USD | -63.83% |
| 2023 Q4 | 17.13 Million USD | -12.81% |
| 2023 FY | 17.13 Million USD | 324.14% |
| 2023 Q2 | 21.63 Million USD | 1380.63% |
| 2022 Q2 | 9.73 Million USD | -23.57% |
| 2022 Q1 | 12.74 Million USD | -8.98% |
| 2022 Q4 | 4.03 Million USD | -39.46% |
| 2022 Q3 | 6.67 Million USD | -31.48% |
| 2022 FY | 4.03 Million USD | -71.15% |
| 2021 Q2 | 521 Thousand USD | 369.37% |
| 2021 Q3 | 961 Thousand USD | 84.45% |
| 2021 Q4 | 13.99 Million USD | 1356.61% |
| 2021 FY | 13.99 Million USD | 27347.06% |
| 2021 Q1 | 111 Thousand USD | 117.65% |
| 2020 Q3 | 737.09 Million USD | 3.87% |
| 2020 Q2 | 709.65 Million USD | -4.16% |
| 2020 FY | 51 Thousand USD | 628.57% |
| 2020 Q1 | 740.42 Million USD | 7.98% |
| 2020 Q4 | 51 Thousand USD | -99.99% |
| 2019 Q4 | 685.72 Million USD | 1.41% |
| 2019 Q3 | 676.16 Million USD | 1.81% |
| 2019 Q2 | 664.16 Million USD | 0.63% |
| 2019 FY | 7000.00 USD | -100.0% |
| 2019 Q1 | 659.98 Million USD | 12.47% |
| 2018 Q1 | 528.02 Million USD | 0.66% |
| 2018 FY | 586.8 Million USD | 11.86% |
| 2018 Q4 | 586.8 Million USD | 2.19% |
| 2018 Q3 | 574.2 Million USD | 4.71% |
| 2018 Q2 | 548.37 Million USD | 3.85% |
| 2017 Q4 | 524.56 Million USD | 0.74% |
| 2017 Q3 | 520.71 Million USD | 155.31% |
| 2017 Q1 | 204.57 Million USD | 2.81% |
| 2017 FY | 524.56 Million USD | 163.62% |
| 2017 Q2 | 203.95 Million USD | -0.3% |
| 2016 Q4 | 198.98 Million USD | 20.44% |
| 2016 Q1 | 128.93 Million USD | 3.86% |
| 2016 FY | 198.98 Million USD | 60.29% |
| 2016 Q2 | 156.19 Million USD | 21.14% |
| 2016 Q3 | 165.21 Million USD | 5.78% |
| 2015 FY | 124.14 Million USD | -0.51% |
| 2015 Q1 | 117.16 Million USD | -6.1% |
| 2015 Q4 | 124.14 Million USD | 1.44% |
| 2015 Q3 | 122.37 Million USD | 2.0% |
| 2015 Q2 | 119.98 Million USD | 2.41% |
| 2014 Q4 | 124.77 Million USD | 5.67% |
| 2014 Q2 | 118.4 Million USD | 10.28% |
| 2014 Q1 | 107.36 Million USD | 22.64% |
| 2014 FY | 124.77 Million USD | 42.53% |
| 2014 Q3 | 118.08 Million USD | -0.28% |
| 2013 FY | 87.54 Million USD | -2.74% |
| 2013 Q1 | 89.06 Million USD | -1.05% |
| 2013 Q2 | 89.94 Million USD | 0.99% |
| 2013 Q3 | 88.68 Million USD | -1.4% |
| 2013 Q4 | 87.54 Million USD | -1.28% |
| 2012 Q1 | 91.07 Million USD | -4.1% |
| 2012 FY | 90.01 Million USD | -5.23% |
| 2012 Q3 | 94.3 Million USD | 3.26% |
| 2012 Q2 | 91.32 Million USD | 0.27% |
| 2012 Q4 | 90.01 Million USD | -4.56% |
| 2011 FY | 94.97 Million USD | -39.39% |
| 2011 Q4 | 94.97 Million USD | -35.24% |
| 2011 Q2 | 152.24 Million USD | -1.08% |
| 2011 Q1 | 153.91 Million USD | -1.77% |
| 2011 Q3 | 146.65 Million USD | -3.67% |
| 2010 Q4 | 156.69 Million USD | 1.52% |
| 2010 Q2 | 160.57 Million USD | -0.91% |
| 2010 Q3 | 154.34 Million USD | -3.88% |
| 2010 Q1 | 162.05 Million USD | -3.72% |
| 2010 FY | 156.69 Million USD | -6.91% |
| 2009 Q1 | 170.38 Million USD | 2.78% |
| 2009 Q3 | 169.01 Million USD | -1.42% |
| 2009 Q2 | 171.46 Million USD | 0.63% |
| 2009 FY | 168.32 Million USD | 1.54% |
| 2009 Q4 | 168.32 Million USD | -0.41% |
| 2008 Q2 | 152.84 Million USD | -1.24% |
| 2008 Q4 | 165.77 Million USD | 0.81% |
| 2008 Q1 | 154.76 Million USD | 50.2% |
| 2008 FY | 165.77 Million USD | 60.88% |
| 2008 Q3 | 164.43 Million USD | 7.59% |
| 2007 Q4 | 103.03 Million USD | 0.0% |
| 2007 Q2 | 121.57 Million USD | 0.0% |
| 2007 FY | 103.03 Million USD | 500.11% |
| 2006 FY | 17.17 Million USD | 0.0% |
| 2006 Q4 | 17.17 Million USD | 0.0% |
| 2004 FY | 22.8 Million USD | 2.94% |
| 2003 FY | 22.15 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Inovalon Holdings, Inc. | 1.97 Billion USD | 99.131% |
| GE HealthCare Technologies Inc. | 32.45 Billion USD | 99.947% |
| Sharecare, Inc. | 613.63 Million USD | 97.208% |
| Progyny, Inc. | 756.62 Million USD | 97.736% |
| Aclarion, Inc. | 2.45 Million USD | -596.446% |
| CareMax, Inc. | 623.3 Million USD | 97.252% |
| Simulations Plus, Inc. | 196.63 Million USD | 91.288% |
| CareCloud, Inc. | 79.51 Million USD | 78.455% |
| Forian Inc. | 59.37 Million USD | 71.148% |
| Bullfrog AI Holdings, Inc. Warrants | 2.77 Million USD | -516.981% |
| Bullfrog AI Holdings, Inc. Common Stock | 2.77 Million USD | -516.981% |
| Minerva Surgical, Inc. | 68.9 Million USD | 75.136% |
| Omnicell, Inc. | 2.22 Billion USD | 99.231% |
| Definitive Healthcare Corp. | 1.82 Billion USD | 99.062% |
| Zhongchao Inc. | 24.41 Million USD | 29.839% |
| Accolade, Inc. | 788.15 Million USD | 97.826% |
| Streamline Health Solutions, Inc. | 41.74 Million USD | 58.958% |
| Ontrak, Inc. | 19.84 Million USD | 13.68% |
| SOPHiA GENETICS SA | 206.15 Million USD | 91.69% |
| R1 RCM Inc. | 4.96 Billion USD | 99.655% |
| Spok Holdings, Inc. | 227.68 Million USD | 92.476% |
| Privia Health Group, Inc. | 999.9 Million USD | 98.287% |
| EUDA Health Holdings Limited | 1.31 Million USD | -1207.203% |
| GeneDx Holdings Corp. | 473.67 Million USD | 96.383% |
| TruBridge, Inc. | 434.42 Million USD | 96.057% |
| Nutex Health, Inc. | 398.24 Million USD | 95.698% |
| Renalytix Plc | 7.97 Million USD | -114.89% |
| Sharecare, Inc. | 613.63 Million USD | 97.208% |
| Health Catalyst, Inc. | 701.81 Million USD | 97.559% |
| 10x Genomics, Inc. | 965.14 Million USD | 98.225% |
| GoodRx Holdings, Inc. | 1.58 Billion USD | 98.922% |
| SCWorx Corp. | 6.27 Million USD | -172.864% |
| Schrödinger, Inc. | 802.95 Million USD | 97.867% |
| HealthEquity, Inc. | 3.23 Billion USD | 99.471% |
| HealthStream, Inc. | 499.94 Million USD | 96.573% |
| MSP Recovery, Inc. | 3.15 Billion USD | 99.458% |
| Augmedix, Inc. | 66.71 Million USD | 74.321% |
| BrightSpring Health Services, Inc. Common Stock | 5.79 Billion USD | 99.704% |
| Ontrak, Inc. | 19.84 Million USD | 13.68% |
| SHL Telemedicine Ltd. | 113.04 Million USD | 84.846% |
| CareCloud, Inc. | 79.51 Million USD | 78.455% |
| Premier, Inc. | 3.42 Billion USD | 99.5% |
| Certara, Inc. | 1.56 Billion USD | 98.904% |
| GeneDx Holdings Corp. | 473.67 Million USD | 96.383% |
| OneMedNet Corporation | 463.05 Thousand USD | -3599.545% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | 5.79 Billion USD | 99.704% |
| EUDA Health Holdings Limited | 1.31 Million USD | -1207.203% |
| HeartBeam, Inc. | 17.13 Million USD | 0.0% |
| CareCloud, Inc. | 79.51 Million USD | 78.455% |
| Mangoceuticals, Inc. | 1.05 Million USD | -1530.293% |
| CareMax, Inc. | 623.3 Million USD | 97.252% |
| Healthcare Triangle, Inc. | 10.04 Million USD | -70.475% |
| National Research Corporation | 122.43 Million USD | 86.008% |
| Aclarion, Inc. | 2.45 Million USD | -596.446% |
| OptimizeRx Corporation | 183.37 Million USD | 90.658% |